Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma.
Hu B, Zou T, Qin W, Shen X, Su Y, Li J, Chen Y, Zhang Z, Sun H, Zheng Y, Wang CQ, Wang Z, Li TE, Wang S, Zhu L, Wang X, Fu Y, Ren X, Dong Q, Qin LX.
Hu B, et al. Among authors: wang x, wang cq, wang z, wang s.
Cancer Res. 2022 Oct 17;82(20):3845-3857. doi: 10.1158/0008-5472.CAN-21-4140.
Cancer Res. 2022.
PMID: 36066408
Free PMC article.